N

Navamedic ASA
OSE:NAVA

Watchlist Manager
Navamedic ASA
OSE:NAVA
Watchlist
Price: 23.5 NOK -2.08% Market Closed
Market Cap: 415.1m NOK
Have any thoughts about
Navamedic ASA?
Write Note

Relative Value

The Relative Value of one NAVA stock under the Base Case scenario is 79.07 NOK. Compared to the current market price of 23.5 NOK, Navamedic ASA is Undervalued by 70%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NAVA Relative Value
Base Case
79.07 NOK
Undervaluation 70%
Relative Value
Price
N
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
67
Median 3Y
1.5
Median 5Y
1.4
Industry
2.6
Forward
0.7
vs History
50
vs Industry
1
Median 3Y
27.4
Median 5Y
17.7
Industry
23
Forward
14.2
vs History
34
vs Industry
1
Median 3Y
61.3
Median 5Y
19.1
Industry
17.8
vs History
11
vs Industry
32
Median 3Y
13
Median 5Y
7.5
Industry
25.4
vs History
92
vs Industry
31
Median 3Y
2.9
Median 5Y
2.6
Industry
2.2
vs History
80
vs Industry
66
Median 3Y
1.5
Median 5Y
1.4
Industry
2.8
Forward
0.8
vs History
93
vs Industry
58
Median 3Y
3.6
Median 5Y
3.7
Industry
5.4
vs History
63
vs Industry
30
Median 3Y
14.7
Median 5Y
13.1
Industry
13.7
Forward
8.2
vs History
57
vs Industry
27
Median 3Y
18.3
Median 5Y
13.4
Industry
17.2
Forward
7.4
vs History
28
vs Industry
1
Median 3Y
61.5
Median 5Y
21.2
Industry
16.5
vs History
14
vs Industry
25
Median 3Y
22.8
Median 5Y
15.7
Industry
19.3
vs History
85
vs Industry
45
Median 3Y
2
Median 5Y
1.8
Industry
2

Multiples Across Competitors

NAVA Competitors Multiples
Navamedic ASA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Navamedic ASA
OSE:NAVA
409.7m NOK 0.8 16.6 7.5 9.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
746.8B USD 18.3 89.2 48 53.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
365.6B USD 4.2 24.9 12 15.7
US
Merck & Co Inc
NYSE:MRK
249.1B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.6B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.4B CHF 4.2 12.6 10 14.8
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.4 169.3 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
NO
N
Navamedic ASA
OSE:NAVA
Average P/E: 31
16.6
2 021%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
89.2
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.9
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.4
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top